ES2185188T3 - Composiciones farmaceuticas de prostaglandinas. - Google Patents

Composiciones farmaceuticas de prostaglandinas.

Info

Publication number
ES2185188T3
ES2185188T3 ES98934967T ES98934967T ES2185188T3 ES 2185188 T3 ES2185188 T3 ES 2185188T3 ES 98934967 T ES98934967 T ES 98934967T ES 98934967 T ES98934967 T ES 98934967T ES 2185188 T3 ES2185188 T3 ES 2185188T3
Authority
ES
Spain
Prior art keywords
prostaglandinas
pharmaceutical compositions
sub
compounds
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98934967T
Other languages
English (en)
Inventor
Soldato Piero Del
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nicox SA
Original Assignee
Nicox SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox SA filed Critical Nicox SA
Application granted granted Critical
Publication of ES2185188T3 publication Critical patent/ES2185188T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

La invención se refiere a compuestos de fórmula general A-X{sub,1}-NO{sub,2}, en la que A contiene un residuo de prostaglandina y X{sub,1} es un puente de enlace bivalente, así como a composiciones farmacéuticas que contienen dichos compuestos.
ES98934967T 1997-06-19 1998-06-17 Composiciones farmaceuticas de prostaglandinas. Expired - Lifetime ES2185188T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001440A IT1292377B1 (it) 1997-06-19 1997-06-19 Composizioni farmaceutiche a base di prostaglandine

Publications (1)

Publication Number Publication Date
ES2185188T3 true ES2185188T3 (es) 2003-04-16

Family

ID=11377397

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98934967T Expired - Lifetime ES2185188T3 (es) 1997-06-19 1998-06-17 Composiciones farmaceuticas de prostaglandinas.

Country Status (19)

Country Link
US (1) US6211233B1 (es)
EP (1) EP0989972B1 (es)
JP (1) JP4394170B2 (es)
KR (1) KR20010013625A (es)
CN (1) CN1260778A (es)
AT (1) ATE225771T1 (es)
AU (1) AU740683B2 (es)
BR (1) BR9810163B1 (es)
CA (1) CA2292836C (es)
DE (1) DE69808619T2 (es)
DK (1) DK0989972T3 (es)
ES (1) ES2185188T3 (es)
HU (1) HUP0004071A3 (es)
IL (1) IL132690A (es)
IT (1) IT1292377B1 (es)
PT (1) PT989972E (es)
RU (1) RU2000100807A (es)
SI (1) SI0989972T1 (es)
WO (1) WO1998058910A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
AU3713600A (en) 1999-03-01 2000-09-21 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
IT1311923B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.
WO2002060387A2 (en) * 2001-01-30 2002-08-08 Pharmaceutical Research Corporation Use of prostaglandin analogs for treatment of cardiac conditions
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7011854B2 (en) * 2002-02-04 2006-03-14 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
EP1562975A2 (en) * 2002-10-25 2005-08-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
NZ548271A (en) * 2004-01-05 2010-01-29 Nicox Sa Prostaglandin nitrooxyderivatives
WO2007000641A2 (en) * 2005-06-29 2007-01-04 Pfizer Inc. Prostaglandin derivatives
EP1917239A1 (en) * 2005-06-29 2008-05-07 Pfizer, Inc. Fluoroprostaglandins nitroderivatives
WO2007073226A1 (en) * 2005-12-20 2007-06-28 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda Method for treating a mammal by administration of a compound having the ability to release co
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
CA2647859C (en) 2006-03-29 2016-01-05 Nitromed, Inc. Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
US8041859B2 (en) * 2007-11-05 2011-10-18 Honywell International Inc. Apparatus and method for connectivity in networks capable of non-disruptively disconnecting peripheral devices
WO2012145520A2 (en) 2011-04-19 2012-10-26 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
WO2013013179A1 (en) 2011-07-21 2013-01-24 Alfama, Inc. Ruthenium carbon monoxide releasing molecules and uses thereof
WO2014111957A1 (en) 2013-01-21 2014-07-24 Apparao Satyam Nitric oxide releasing prodrugs of therapeutic agents
CN113943266A (zh) * 2021-11-18 2022-01-18 广州楷石医药有限公司 一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3371199D1 (en) * 1982-08-24 1987-06-04 Teijin Ltd Novel 6-nitroprostaglandin derivatives, process for production thereof, and use thereof
SE463851B (sv) 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
IT1243367B (it) 1990-07-26 1994-06-10 Italfarmaco Spa Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5328933A (en) * 1992-10-28 1994-07-12 Allergan, Inc. Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or aryl aliphatic derivatives and homologues
KR100387359B1 (ko) 1994-05-10 2003-08-27 니콕스 에스. 에이. 항-염증성,비알러지성및항-혈전성을가지는니트로화합물들과그들의조성물들
US5625083A (en) * 1995-06-02 1997-04-29 Bezuglov; Vladimir V. Dinitroglycerol esters of unsaturated fatty acids and prostaglandins

Also Published As

Publication number Publication date
BR9810163A (pt) 2000-08-08
PT989972E (pt) 2003-02-28
EP0989972B1 (en) 2002-10-09
DE69808619T2 (de) 2003-06-12
CA2292836A1 (en) 1998-12-30
HUP0004071A2 (hu) 2001-04-28
WO1998058910A1 (en) 1998-12-30
RU2000100807A (ru) 2002-02-27
US6211233B1 (en) 2001-04-03
EP0989972A1 (en) 2000-04-05
HUP0004071A3 (en) 2002-12-28
ITMI971440A1 (it) 1998-12-19
SI0989972T1 (en) 2003-04-30
CA2292836C (en) 2010-03-02
ITMI971440A0 (es) 1997-06-19
JP4394170B2 (ja) 2010-01-06
DE69808619D1 (de) 2002-11-14
IT1292377B1 (it) 1999-02-08
AU8438698A (en) 1999-01-04
JP2002506440A (ja) 2002-02-26
AU740683B2 (en) 2001-11-08
IL132690A0 (en) 2001-03-19
DK0989972T3 (da) 2003-02-10
BR9810163B1 (pt) 2009-01-13
ATE225771T1 (de) 2002-10-15
IL132690A (en) 2004-06-01
KR20010013625A (ko) 2001-02-26
CN1260778A (zh) 2000-07-19

Similar Documents

Publication Publication Date Title
ES2185188T3 (es) Composiciones farmaceuticas de prostaglandinas.
ES2186013T3 (es) Nitratos organicos con actividad antitrombotica.
TR199902368T2 (xx) S�lfonamid t�revleri.
CO5050332A1 (es) Composiciones fungicidas que comprenden 2-metoxibenzofenonas
DK0927161T3 (da) Substitueret cyklisk amin-metalloproteaseinhibitorer
PA8423701A1 (es) Nuevos plaguicidas
BR9611362A (pt) Composicões detergentes
PT584347E (pt) Compostos de xantina hidroxilados enantiomericos
BR9806296A (pt) Derivados de ácido sulfìnico e sua preparação e uso
IL107870A0 (en) Pharmaceutical compositions having antidepressant activity comprising pramipexol
DE69815302D1 (de) Glaszusammensetzung zur vermeidung der alkali-kiesel-kieselsäure reaktion
EA200400708A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
ES2163239T3 (es) Nuevos derivados cromenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MA27862A1 (fr) Composition pharmaceutique
DE69939424D1 (de) Parfümierte Waschmitteltablette
BR9809643A (pt) Compostos heterocìclicos, seu processo de preparo e as composições farmacêuticas que os contêm
ES2194097T3 (es) Composiciones de fosfolipidos modificados con silicona.
BR9801448A (pt) Compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos.
SE9604582D0 (sv) Novel compounds
ES2159921T3 (es) Imidazolinas sustituidas por un nucleo heterociclico, como 2-alfa-antagonistas.
DK0977871T3 (da) Neurotrypsin
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
DE59808166D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum
CO4700450A1 (es) Nuevos azepanos y homologos de su anillo
ES2162126T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.